Edition:
United States

Regenxbio Inc (RGNX.OQ)

RGNX.OQ on NASDAQ Stock Exchange Global Select Market

59.17USD
15 Oct 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$59.17
Open
$60.64
Day's High
$60.72
Day's Low
$58.03
Volume
158,896
Avg. Vol
189,255
52-wk High
$85.05
52-wk Low
$23.25

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 40.03 0.300
Mar '18 132.39 3.041
FY 2017 Dec '17 2.04 -0.513
Sep '17 1.34 -0.669
Jun '17 6.56 -0.472
Mar '17 0.46 -0.825
FY 2016 Dec '16 1.70 -0.741
Sep '16 0.12 -0.686
Jun '16 2.38 -0.548
Mar '16 0.39 -0.409
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 2 10.00 20.00 0.00 2.00
Quarter Ending Mar-19 1 0.64 0.64 0.64 --
Year Ending Dec-18 6 194.55 232.40 172.00 8.12
Year Ending Dec-19 6 13.66 18.84 6.39 10.00
Earnings (per share)
Quarter Ending Dec-18 2 -0.84 -0.80 -0.88 -0.73
Quarter Ending Mar-19 1 -1.28 -1.28 -1.28 --
Year Ending Dec-18 3 1.66 1.71 1.60 -3.06
Year Ending Dec-19 3 -4.03 -3.37 -4.77 -3.08
LT Growth Rate (%) 1 3.00 3.00 3.00 -42.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 29.43 119.85 32.14
P/E High - Last 5 Yrs. -- 284.29 46.82
P/E Low - Last 5 Yrs. -- 95.75 24.71
Beta -- 0.63 0.87
Price to Sales (TTM) 12.64 109.82 6.55
Price to Book (MRQ) 6.47 13.72 4.00
Price to Tangible Book (MRQ) 7.01 20.21 6.10
Price to Cash Flow (TTM) 27.34 69.50 21.51
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.68
Dividend Yield - 5 Year Avg -- 0.20 1.45
Dividend 5 Year Growth Rate -- 2.61 -5.91
Payout Ratio(TTM) 0.00 5.68 46.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 510.04 157.56 7.91
Sales (TTM) vs TTM 1 Yr. Ago 1,889.11 91.25 6.56
Sales - 5 Yr. Growth Rate -- 25.47 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago 163.63 297.15 26.63
EPS (TTM) vs TTM 1 Yr. Ago 179.31 -- --
EPS - 5 Yr. Growth Rate -- 25.12 7.65
Capital Spending - 5 Yr. Growth Rate -- 39.11 8.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.22
Current Ratio (MRQ) 17.40 5.52 2.99
LT Debt to Equity (MRQ) 0.00 15.33 11.31
Total Debt to Equity (MRQ) 0.00 18.80 14.15
Interest Coverage (TTM) -- -216.32 34.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 96.26 32.64 54.36
Gross Margin - 5 Yr. Avg. -- 52.76 53.16
EBITD Margin (TTM) 41.91 -- --
EBITD - 5 Yr. Avg -- -164.07 16.13
Operating Margin (TTM) 40.08 -618.88 3.36
Operating Margin - 5 Yr. Avg. -- -178.92 11.28
Pre-Tax Margin (TTM) 46.63 -615.68 3.79
Pre-Tax Margin - 5 Yr. Avg. -- -181.48 11.54
Net Profit Margin (TTM) 44.44 -604.79 0.60
Net Profit Margin - 5 Yr. Avg. -- -179.91 7.83
Effective Tax Rate (TTM) 4.70 11.98 20.73
Effective Tax Rate - 5 Yr. Avg. -- 19.65 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 1,264,734 24,741,437 725,680,242
Net Income/Employee (TTM) 562,086 1,102,410 84,001,075
Receivable Turnover (TTM) 445.62 4.18 5.06
Inventory Turnover (TTM) -- 2.14 3.65
Asset Turnover (TTM) 0.63 0.39 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 27.89 0.35 9.83
Return on Assets - 5 Yr. Avg. -- 3.11 10.94
Return on Investment (TTM) 29.37 1.96 12.83
Return on Investment - 5 Yr. Avg. -- 2.91 14.05
Return on Equity (TTM) 29.54 1.12 14.95
Return on Equity - 5 Yr. Avg. -- -0.97 15.39
  1 Year 3 Year 5 Year
Sales % 126.48 19.31 --
EPS (TTM) % -2.71 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Regenxbio Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -12.22 -12.45 33 59
13 Week -22.07 -24.78 28 76
26 Week 102.07 83.06 95 56
52 Week 88.86 66.92 89 83
YTD 91.13 77.16 92 84
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 77.21%
# of Holders: 262
Total Shares Held: 27,005,035
3 Mo. Net Change: 393,619
# New Positions: 8
# Closed Positions: 3
# Increased Positions: 21
# Reduced Positions: 9
# Net Buyers: 12
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.